SeaStar Medical’s Device to Treat Inflammation in ESRD Receives FDA Breakthrough Designation
Effects of SGLT2i on Renal Outcomes Across Cardiovascular-Kidney-Metabolic Conditions
Baxter Resumes Production of Peritoneal Dialysis Solutions